Last updated: 2026-09-10 13:08:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
The Cooper Companies, Inc. (COO) operates in the OPHTHALMIC GOODS sector and is listed on NASDAQ. The stock is currently priced at $52.41, with a market capitalization of $13.20B and a P/E ratio of 21.71. Over the past 52 weeks, its price has ranged from $51.63 to $89.83. This page covers its latest market performance, valuation, price trends and company information.
$13.20B | |
$53.28 | |
$115.90 | |
$2.54 | |
$63.48 | |
249.65K | |
2.36M | |
21.71 | |
$89.83 | |
$51.63 | |
-- | |
-- |
The Cooper Companies, Inc. (COO) is trading at $52.41 in pre-market trading as of 2026-09-10 13:07:00, down 17.44% ($11.07) from the previous close of $63.48
Pre-market trading shows how investors are pricing COO before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, The Cooper Companies, Inc. (COO) moved from $70.09 to $52.41, representing a decline of 25.22% ($17.68).
The stock traded between $51.63 and $71.07 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.09 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.0%
COO is currently trading at $52.41, placing it 2.0% of the way from its 52-week low of $51.63 to its 52-week high of $89.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
| Industry | OPHTHALMIC GOODS |
| Employees | 15000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of The Cooper Companies, Inc. (COO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.